Active Not RecruitingNCT06317636
Propofol-Enhanced Assessment of Ketamine for Chronic Pain and Depression
Medication studyAges 18–70United States
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
- Listed locations
- StanfordSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 28, 2025
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 40
- Sponsor
- Stanford University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT06317636
- Official title
Show the full official title
Randomized, Double-blind, Placebo-controlled, Single-center, Noninferiority Trial of Ketamine Given During Sedation to Patients With Chronic Pain and Depression
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Stanford
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Stanford University, a university.
Does this study involve medication?
Yes. The study involves medication, including ketamine and Normal saline.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
